bisbenzimidazole has been researched along with Bone Cancer in 2 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Indovina, P | 1 |
| Rainaldi, G | 1 |
| Santini, MT | 1 |
| Boschman, GA | 1 |
| Rens, W | 1 |
| Manders, EM | 1 |
| Slater, RM | 1 |
| Versteeg, R | 1 |
| Aten, JA | 1 |
2 other studies available for bisbenzimidazole and Bone Cancer
| Article | Year |
|---|---|
Three-dimensional cell organization leads to a different type of ionizing radiation-induced cell death: MG-63 monolayer cells undergo mitotic catastrophe while spheroids die of apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; bcl-2-Associated X Protein; Bisbenzimidazole; Blotting, | 2007 |
Detection of recurrent chromosome abnormalities in Ewing's sarcoma and peripheral neuroectodermal tumor cells using bivariate flow karyotyping.
Topics: Bisbenzimidazole; Bone Neoplasms; Chromomycin A3; Chromosome Aberrations; Chromosomes, Human, Pair 1 | 1992 |